Jinfeng Shen

477 total citations
7 papers, 279 citations indexed

About

Jinfeng Shen is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Jinfeng Shen has authored 7 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Infectious Diseases. Recurrent topics in Jinfeng Shen's work include Cancer-related Molecular Pathways (3 papers), RNA Interference and Gene Delivery (2 papers) and Autoimmune Neurological Disorders and Treatments (1 paper). Jinfeng Shen is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), RNA Interference and Gene Delivery (2 papers) and Autoimmune Neurological Disorders and Treatments (1 paper). Jinfeng Shen collaborates with scholars based in Sweden, China and Netherlands. Jinfeng Shen's co-authors include Vladimir J.N. Bykov, Klas G. Wiman, Jérémy Lambert, Pierre Hainaut, Nicole Zache, Jan Bergman, Margareta Wilhelm, I Eckhardt, Andrew J. Gentles and M. Ryan Corces and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Oncogene and Cell stem cell.

In The Last Decade

Jinfeng Shen

6 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinfeng Shen Sweden 5 216 152 45 36 32 7 279
Malti Nikrad United States 4 352 1.6× 141 0.9× 21 0.5× 31 0.9× 74 2.3× 6 387
Aurora Chinnici Italy 6 207 1.0× 147 1.0× 13 0.3× 27 0.8× 70 2.2× 9 330
Anthony M. Boutelle United States 4 215 1.0× 109 0.7× 16 0.4× 29 0.8× 93 2.9× 4 320
Mallika Ramakrishnan Germany 8 134 0.6× 134 0.9× 25 0.6× 12 0.3× 79 2.5× 8 299
Michelle T. Ashworth United States 6 212 1.0× 221 1.5× 18 0.4× 10 0.3× 27 0.8× 9 320
Tracey Perry United Kingdom 7 195 0.9× 87 0.6× 64 1.4× 113 3.1× 103 3.2× 10 360
Kendra R. Cook United States 5 105 0.5× 214 1.4× 11 0.2× 27 0.8× 42 1.3× 6 317
Sonia Zaghdoudi France 4 142 0.7× 95 0.6× 10 0.2× 54 1.5× 70 2.2× 4 256
Hiroyuki Yoda Japan 10 194 0.9× 104 0.7× 12 0.3× 9 0.3× 51 1.6× 20 285
Joanna Barankiewicz Poland 7 143 0.7× 41 0.3× 23 0.5× 31 0.9× 22 0.7× 20 258

Countries citing papers authored by Jinfeng Shen

Since Specialization
Citations

This map shows the geographic impact of Jinfeng Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinfeng Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinfeng Shen more than expected).

Fields of papers citing papers by Jinfeng Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinfeng Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinfeng Shen. The network helps show where Jinfeng Shen may publish in the future.

Co-authorship network of co-authors of Jinfeng Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Jinfeng Shen. A scholar is included among the top collaborators of Jinfeng Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinfeng Shen. Jinfeng Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
2.
Shen, Jinfeng, Aiping Wang, Lingjuan Liu, et al.. (2020). Clinical characteristics of anti-N-methyl-D-aspartate receptor encephalitis in children.. PubMed. 45(1). 47–54. 4 indexed citations
3.
He, Danfeng, et al.. (2018). [The effects of methylprednisolone on NLRP3 inflammasome in rats with acute lung injury Induced by Phosgene].. PubMed. 36(8). 573–579. 4 indexed citations
4.
Chao, Mark P., Andrew J. Gentles, Feng Lan, et al.. (2017). Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease. Cell stem cell. 20(3). 329–344.e7. 90 indexed citations
5.
Shen, Jinfeng, Ellen H. van den Bogaard, Evelyn N. Kouwenhoven, et al.. (2013). APR-246/PRIMA-1 MET rescues epidermal differentiation in skin keratinocytes derived from EEC syndrome patients with p63 mutations. Proceedings of the National Academy of Sciences. 110(6). 2157–2162. 35 indexed citations
6.
Shen, Jinfeng, et al.. (2010). PRIMA-1MET/APR-246 targets mutant forms of p53 family members p63 and p73. Oncogene. 29(49). 6442–6451. 51 indexed citations
7.
Zache, Nicole, Jérémy Lambert, Jinfeng Shen, et al.. (2008). Mutant p53 targeting by the low molecular weight compound STIMA‐1. Molecular Oncology. 2(1). 70–80. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026